With OMX Ventures and as the CEO of General Inception Paul leverages his broad technology background, real world research experience, and over a decade of prior founder/CEO operating experience to partner with scientific founders in building commercial companies from scratch. Paul has served as Director or Board Observer at more than 25 companies to date, including 10X Genomics (NASDAQ: TXG), Twist Bioscience (NASDAQ: TWST), Inscripta and QuantaLife (NASDAQ: BIO).
Education: PhD Applied Mechanics/Engineering Science, MS Bioengineering UC San Diego (UCSD), MS Mech/Aero Engineering, BS Mech University of Virginia (UVA)
